Mukka Proteins Acquires Full Stake in Ento Proteins for Rs. 32 Lakh
Filing Summary
Mukka Proteins Ltd has announced the acquisition of an additional 1,000 equity shares in Ento Proteins Private Limited, increasing its shareholding to 100%. The acquisition, approved by the Board on February 12, 2026, involves a total consideration of Rs. 32,30,000. Ento Proteins, a manufacturer of insect meal and oil, will become a wholly owned subsidiary of Mukka Proteins. The transaction is part of Mukka’s strategic investment plans to expand its alternate proteins business. The acquisition is expected to be completed by June 30, 2026.
Mukka Proteins Ltd has informed the National Stock Exchange of India Limited and BSE Limited about its decision to acquire additional shares in Ento Proteins Private Limited. The Board of Directors approved the acquisition of 1,000 equity shares, each with a face value of Rs. 100, from existing shareholders. This transaction, valued at Rs. 32,30,000, will result in Mukka Proteins holding 100% of Ento Proteins, making it a wholly owned subsidiary.
The financial terms of the acquisition involve a cash consideration of Rs. 32,30,000 for the purchase of 1,000 equity shares. Prior to this acquisition, Mukka Proteins held a 74.01% stake in Ento Proteins. The additional shares will increase the company’s shareholding by 25.99%, resulting in full ownership. The acquisition is conducted on an arm’s length basis, as Ento Proteins is a related party under the Companies Act, 2013.
Ento Proteins Private Limited operates in the manufacturing sector, specifically producing insect meal and insect oil. The company reported a turnover of Rs. 7,46,27,305 for the financial year 2024-25, with a profit after tax of Rs. 49,47,474. The acquisition aligns with Mukka Proteins’ strategic plans to expand its presence in the alternate proteins market. This move is part of the company’s broader strategy to enhance its product offerings in the protein sector.
The acquisition does not require any governmental or regulatory approvals, and the completion is anticipated by June 30, 2026. The transaction was discussed and approved during the Board meeting held on February 12, 2026, which commenced at 4:00 p.m. and concluded at 4:45 p.m. The details of the acquisition were disclosed in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Mukka Proteins Ltd is engaged in the production and distribution of fish meal and fish oil. The company focuses on expanding its product portfolio in the protein sector, with strategic investments aimed at enhancing its market position in alternate proteins. Mukka Proteins continues to explore opportunities to strengthen its business operations and increase shareholder value through targeted acquisitions and partnerships.